Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-27

Clinical Trial Update: Thorough QT/QTC (TQT) Clinical Trial to Evaluate the Effect of Zoliflodacin on Cardiac Repolarization in Healthy Male and Female Subjects [Phase 1]

View source ↗

Summary

Phase 1 thorough QT/QTc study evaluating zoliflodacin's effect on cardiac repolarization in healthy adults completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zoliflodacin (zoliflodacin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Electrocardiogram Repolarisation Abnormality, Gonococcal Infection | Phase 1 | Status: COMPLETED | Results posted: 2020-03-27